Skip to main content
SpringerLink
Log in

Hepatolithiasis (Intrahepatic Stone) During Octreotide Therapy for Acromegaly: A Case Report

  • Published:
Pituitary Aims and scope Submit manuscript

Abstract

We report a case of hepatolithiasis (intrahepatic stone) complicated by gram-negative sepsis in a 37 year old male with acromegaly being treated with octreotide. As a child, he had suffered a traumatic injury to his liver requiring the surgical repair of a laceration. This is the first reported case of hepatolithiasis during octreotide therapy. Gallstones and bile sludge are common side effects of octreotide therapy but rarely become symptomatic or require treatment. Hepatolithiasis is uncommon in western countries but is quite prevalent in East Asia and is often associated with a predisposing condition that causes intrahepatic bile stasis (eg. bile duct stricture). In addition to its known effect on gallbladder stasis, octreotide alters bile acid composition and may thus hasten intrahepatic sludge and stone formation. Extra caution should be taken in using octreotide or its long-acting analog in patients otherwise predisposed to intrahepatic bile stasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Dowling RH, Hussaini SH, Murphy GM, Wass JAH. Gallstones during octreotide therapy. Digestion 1993;54(Suppl 1);107–120.

    Google Scholar 

  2. Ko CW, Lee SP. Gallstone formation, local factors. Gastroenterol Clin NA 1999;28:99–115.

    Google Scholar 

  3. Redfern JS, Fortuner II WJ. Octreotide-associated biliary tract dysfunction and gallstone formation: Pathophysiology and management. Am J Gastroenterol 1995;90:1042–1052.

    Google Scholar 

  4. Leung JW, Y u AS. Hepatolithiasis and biliary parasites. Baillieres Clin Gastroenterol 1997;11:681–706.

    Google Scholar 

  5. Pausawasdi A, Watanapa P. Hepatolithiasis: Epidemiology and classification. Hepatogastroenterology 1997;44:314–316.

    Google Scholar 

  6. Newman CB, Me lmed S, Snyder PJ, Young WF, Boyajy LD, Levy R, Stewart WN, Klibanski A, Molitch ME, Gagel RF, Boyd AE, Sheeler L, Cook D, Malarkey WB, Jackson IMD, Vance ML, Thorner MO, Ho PJ, Jaffe CA, Frohman LA, Kleinberg DL. Safety and efficacy of long term octreotide therapy of acromegaly: Results of a multicenter trial in 103 patients-a clinical research center study. J Clin Endocrinol Metab 1995;80:2768–2775.

    Google Scholar 

  7. Hussaini SH, Pereira SP, Veysey MJ, Kennedy C, Jenkins P, Murphy GM, Wass JAH, Dowling RH. Roles of gall bladder emptying and intestinal transit in the pathogenesis of octreotide induced gall bladder stones. Gut 1996;38:775–783.

    Google Scholar 

  8. Moser AJ, Abedin MZ, Giurgiu DIN, Roslyn JJ. Octreotide promotes gallbladder-absorption in prairie dogs: A potential cause of gallstones. Gastroenterology 1995;108:1547–1555.

    Google Scholar 

  9. Hussaini SH, Murphy GM, Kennedy C, Besser GM, Wass JAH, Dowling RH. The role of bile composition and physical chemistry in the pathogenesis of octreotide-associated gallbladder stones. Gastroenterology 1994;107:1503–1513.

    Google Scholar 

  10. Veysey MJ, Thomas LA, Mallet AI, Jenkins PJ, Besser GM, Wass JAH, Murphy GM, Dowling RH. Prolonged large bowel transit increases serum deoxycholic acid: a risk factor for octreotide induced gallstones. Gut 1999;44:675–681.

    Google Scholar 

  11. Magnusson I, Einarsson K, Angelin B, Nyberg B, Berg-ström K, Thulin L. Effects of somatostatin on hepatic bile formation. Gastroenterology 1989;96:206–212.

    Google Scholar 

  12. Ahrendt SA, McGuire GE, Pitt HA, Lillemoe KD. Why does somatostatin cause gallstones? AmJ Surg 1991;161:177–183.

    Google Scholar 

  13. Chu KM, Lo CM, Liu CL, Fan ST. Malignancy associated with hepatolithiasis. Hepatogastroenterology 1997;44:352–357.

    Google Scholar 

  14. Leung JW, Cotton PB. Endoscopic nasobiliary catheter drainage in biliary and pancreatic disease. Am J Gastroenterol 1991;86:389–394.

    Google Scholar 

  15. Yeh YH, Huang MH, Yang JC, et al. Percutaneous transhepatic cholangioscopy and lithotripsy in the treatment of intrahepatic stones: a study with 5 year follow-up. Gastrointest Endosc 1995;42:13–18.

    Google Scholar 

  16. Choi S, Choi TK, Wong J. Intraoperative flexible choledochoscopy for intrahepatic and extrahepatic biliary calculi. Surgery 1987;101:571–576.

    Google Scholar 

  17. Hung CJ, Lin PW. Role of right hepatic lobectomy in the treatment of isolated right-sided hepatolithiasis. Surgery 1997;121:130–134.

    Google Scholar 

  18. Fan ST, Lai EC, Wong J. Hepatic resection for hepatolithiasis. Arch Surg 1993;128:1070–1074.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Endocrinology, Metabolism and Nutrition, Mayo Clinic, Rochester, MN

    Michael Todd Sheehan

  2. Division of Endocrinology, Metabolism and Nutrition, Mayo Clinic, Rochester, MN

    Todd Bert Nippoldt

Authors
  1. Michael Todd Sheehan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Todd Bert Nippoldt
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sheehan, M.T., Nippoldt, T.B. Hepatolithiasis (Intrahepatic Stone) During Octreotide Therapy for Acromegaly: A Case Report. Pituitary 3, 229–232 (2000). https://doi.org/10.1023/A:1012880113759

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1012880113759

Search

Navigation